208 related articles for article (PubMed ID: 14679400)
1. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy.
Mimura H; Kanazawa S; Yasui K; Fujiwara H; Hyodo T; Mukai T; Dendo S; Iguchi T; Hiraki T; Koshima I; Hiraki Y
Acta Med Okayama; 2003 Oct; 57(5):227-34. PubMed ID: 14679400
[TBL] [Abstract][Full Text] [Related]
2. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
Li L; Feng J; Zeng XQ; Li YH
J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous sclerotherapy of peripheral venous malformations in pediatric patients.
Gulsen F; Cantasdemir M; Solak S; Gulsen G; Ozluk E; Numan F
Pediatr Surg Int; 2011 Dec; 27(12):1283-7. PubMed ID: 21818522
[TBL] [Abstract][Full Text] [Related]
4. Intralesional sclerotherapy for subcutaneous venous malformations in children.
Uehara S; Osuga K; Yoneda A; Oue T; Yamanaka H; Fukuzawa M
Pediatr Surg Int; 2009 Aug; 25(8):709-13. PubMed ID: 19582463
[TBL] [Abstract][Full Text] [Related]
5. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations.
Jain R; Bandhu S; Sawhney S; Mittal R
J Clin Ultrasound; 2002 Sep; 30(7):416-23. PubMed ID: 12210459
[TBL] [Abstract][Full Text] [Related]
6. Treatment of venous malformations with sclerosant in microfoam form.
Cabrera J; Cabrera J; Garcia-Olmedo MA; Redondo P
Arch Dermatol; 2003 Nov; 139(11):1409-16. PubMed ID: 14623700
[TBL] [Abstract][Full Text] [Related]
7. Sclerotherapy for venous malformations of the glans penis.
Marrocco-Trischitta MM; Nicodemi EM; Stillo F
Urology; 2001 Feb; 57(2):310-3. PubMed ID: 11182343
[TBL] [Abstract][Full Text] [Related]
8. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.
Blaise S; Charavin-Cocuzza M; Riom H; Brix M; Seinturier C; Diamand JM; Gachet G; Carpentier PH
Eur J Vasc Endovasc Surg; 2011 Mar; 41(3):412-7. PubMed ID: 21111641
[TBL] [Abstract][Full Text] [Related]
9. Patient satisfaction after sclerotherapy of venous malformations in children.
Nakahata K; Uehara S; Zenitani M; Nakamura M; Osuga K; Okuyama H
Pediatr Int; 2016 Aug; 58(8):721-5. PubMed ID: 26662951
[TBL] [Abstract][Full Text] [Related]
10. Complications of sclerotherapy for 75 head and neck venous malformations.
Castrén E; Aronniemi J; Klockars T; Pekkola J; Lappalainen K; Vuola P; Salminen P; Pitkäranta A
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1027-36. PubMed ID: 25731642
[TBL] [Abstract][Full Text] [Related]
11. Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations.
Brill R; Deistung A; Gussew A; Goldann C; Stangl F; Uller W; Rosendahl J; Wildgruber M; Wohlgemuth WA
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1083-1089. PubMed ID: 32199800
[TBL] [Abstract][Full Text] [Related]
12. Color duplex-guided sclerotherapy for the treatment of venous malformations.
Yamaki T; Nozaki M; Sasaki K
Dermatol Surg; 2000 Apr; 26(4):323-8. PubMed ID: 10759818
[TBL] [Abstract][Full Text] [Related]
13. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation.
Marrocco-Trischitta MM; Guerrini P; Abeni D; Stillo F
Dermatol Surg; 2002 Feb; 28(2):153-5. PubMed ID: 11860427
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
[TBL] [Abstract][Full Text] [Related]
15. Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief.
Mimura H; Fujiwara H; Hiraki T; Gobara H; Mukai T; Hyodo T; Iguchi T; Yasui K; Kimata Y; Kanazawa S
Eur Radiol; 2009 Oct; 19(10):2474-80. PubMed ID: 19440712
[TBL] [Abstract][Full Text] [Related]
16. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of polidocanol sclerotherapy in alleviating symptoms in patients with venous malformations.
Guzelbey T; Cingoz M; Erdim C; Mutlu IN; Kılıckesmez O
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101698. PubMed ID: 37890587
[TBL] [Abstract][Full Text] [Related]
18. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
[TBL] [Abstract][Full Text] [Related]
19. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
20. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
